NCT03844360RecruitingPhase 4
Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease
Source: ClinicalTrials.gov · Last updated 30 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The investigators' purpose was to assess the feasibility of dosage individualization of the commonly used antineoplastic drugs and anti-infective drugs in children with hematoplastic disease.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 1500 (estimated)
- First submitted
- 12 Feb 2019
- Start date
- 31 Jan 2016
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Wei Zhao
- Diseases
- Childhood cancers
- NCT number
- NCT03844360
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 1500
- From 31 Jan 2016 to the primary completion date, 31 Dec 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- expected survival time less than the treatment cycle;
- patients with other factors that researcher considers unsuitable for inclusion.
Who the study is looking for
- Patients must be diagnosed with hematological neoplasms
- Antineoplastic drugs or anti-infective drugs used as part of regular treatment
Age in the registry: 1 day to 18 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| State Key Laboratory of Experimental Haematology, Department of Paediatric Haematology, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Coordinator of this site? Confirm its status | Tanjin | China | Recruiting |
| Department of Pediatrics, the Affiliated Hospital of Xuzhou Medical University Coordinator of this site? Confirm its status | Xuzhou | China | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.